# A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement

> **NCT05542277** · NA · TERMINATED · sponsor: **PlasFree Ltd.** · enrollment: 130 (actual)

## Conditions studied

- Bleeding
- Bypass Complication
- Valve Replacement

## Interventions

- **DEVICE:** ClearPlasma

## Key facts

- **NCT ID:** NCT05542277
- **Lead sponsor:** PlasFree Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-08
- **Primary completion:** 2025-03-09
- **Final completion:** 2025-03-09
- **Target enrollment:** 130 (ACTUAL)
- **Why stopped:** The study was stopped to evaluate the differences between the indications.
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05542277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05542277, "A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05542277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*